Skip to main content
SpringerLink
Log in

The Expanding Diagnostic Role of Flow Cytometry in Bone Marrow Studies of Patients with Lymphomas and Plasma Cell Disorders

  • Chapter
  • First Online:
Bone Marrow Lymphoid Infiltrates

  • 1181 Accesses

Abstract

Flow cytometry (FCM) is a technique used to evaluate multiple parameters of individual cells (or other particles) by measuring the photons they scatter or emit as they stream individually through a light source. The strength of FCM lies in its ability to evaluate many parameters per cell, combined with a possibility to register data from very high numbers of cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Giaretti W. Origins of flow cytometry and applications in oncology. J Clin Pathol. 1997;50:275–7.

    Article  PubMed  CAS  Google Scholar 

  2. Roederer M. Multiparameter FACS analysis. Curr Protoc Immunol. 2002;Chapter 5:unit 5.8.

    Google Scholar 

  3. Morice WG, Kurtin PJ, Hodnefield JM, Shanafelt TD, Hoyer JD, Remstein ED, et al. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc. 2008;83:776–85.

    Article  PubMed  Google Scholar 

  4. Mancuso P, Calleri A, Antoniotti P, Quarna J, Pruneri G, Bertolini F. If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma. BMC Cancer. 2010;10:644.

    Article  PubMed  Google Scholar 

  5. Moloney M, Shreffler WG. Basic science for the practicing physician: flow cytometry and cell sorting. Ann Allergy Asthma Immunol. 2008;101:544–9.

    Article  PubMed  Google Scholar 

  6. Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay. Clin Lab Med. 2007;27:469–85.

    Article  PubMed  Google Scholar 

  7. Tung JW, Heydari K, Tirouvanziam R, Sahaf B, Parks DR, Herzenberg LA, et al. Modern flow cytometry: a practical approach. Clin Lab Med. 2007;27:453–68.

    Article  PubMed  Google Scholar 

  8. Arnoulet C, Bene MC, Durrieu F, Feuillard J, Fossat C, Husson B, et al. Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: a reference document based on a systematic approach by the GTLLF and GEIL. Cytometry B Clin Cytom. 2010;78:4–10.

    PubMed  Google Scholar 

  9. Carulli G, Cannizzo E, Zucca A, Buda G, Orciuolo E, Marini A, et al. CD45 expression in low-grade B-cell non-Hodgkin’s lymphomas. Leuk Res. 2008;32:263–7.

    Article  PubMed  CAS  Google Scholar 

  10. Hoffkes HG, Schmidtke G, Schmucker U, Uppenkamp M, Brittinger G. Immunophenotyping of B lymphocytes by multiparametric flow cytometry in bone marrow aspirates of healthy adults. Ann Hematol. 1995;71:123–8.

    Article  PubMed  CAS  Google Scholar 

  11. Lucio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia. 1999;13:419–27.

    Article  PubMed  CAS  Google Scholar 

  12. Porwit-MacDonald A, Bjorklund E, Lucio P, van Lochem EG, Mazur J, Parreira A, et al. BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukemia. 2000;14:816–25.

    Article  PubMed  CAS  Google Scholar 

  13. Rawstron AC, Hillmen P. Assessing minimal residual disease in chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2008;3:47–53.

    Article  PubMed  Google Scholar 

  14. Bottcher S, Stilgenbauer S, Busch R, Bruggemann M, Raff T, Pott C, et al. Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis. Leukemia. 2009;23:2007–17.

    Article  PubMed  CAS  Google Scholar 

  15. Gratama JW, D’hautcourt JL, Mandy F, Rothe G, Barnett D, Janossy G, et al. Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry. 1998;33:166–78.

    Article  PubMed  CAS  Google Scholar 

  16. Costa ES, Pedreira CE, Barrena S, Lecrevisse Q, Flores J, Quijano S, et al. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping. Leukemia. 2010;24:1927–33.

    Article  PubMed  CAS  Google Scholar 

  17. Pedreira CE, Costa ES, Arroyo ME, Almeida J, Orfao A. A multidimensional classification approach for the automated analysis of flow cytometry data. IEEE Trans Biomed Eng. 2008;55:1155–62.

    Article  PubMed  Google Scholar 

  18. Pedreira CE, Costa ES, Barrena S, Lecrevisse Q, Almeida J, Van Dongen JJ, et al. Generation of flow cytometry data files with a potentially infinite number of dimensions. Cytometry A. 2008;73:834–46.

    PubMed  Google Scholar 

  19. Pedreira CE, Costa ES, Almeida J, Fernandez C, Quijano S, Flores J, et al. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders. Cytometry A. 2008;73A:1141–50.

    Article  PubMed  CAS  Google Scholar 

  20. Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom. 2007;72 Suppl 1:S14–22.

    PubMed  Google Scholar 

  21. Bene MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European leukemia net work package 10. Leukemia. 2011;25:567–74.

    Article  PubMed  CAS  Google Scholar 

  22. Perez-Andres M, Paiva B, Nieto WG, Caraux A, Schmitz A, Almeida J, et al. Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin Cytom. 2010;78 Suppl 1:S47–60.

    PubMed  Google Scholar 

  23. van Lochem EG, van der Velden VH, Wind HK, Te Marvelde JG, Westerdaal NA, van Dongen JJ. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin Cytom. 2004;60:1–13.

    Article  PubMed  Google Scholar 

  24. McKenna RW, Washington LT, Aquino DB, Picker LJ, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498–507.

    Article  PubMed  CAS  Google Scholar 

  25. Sanchez ML, Almeida J, Vidriales B, Lopez-Berges MC, Garcia-Marcos MA, Moro MJ, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16:1460–9.

    Article  PubMed  CAS  Google Scholar 

  26. Sevilla DW, Colovai AI, Emmons FN, Bhagat G, Alobeid B. Hematogones: a review and update. Leuk Lymphoma. 2010;51:10–9.

    Article  PubMed  Google Scholar 

  27. Caraux A, Klein B, Paiva B, Bret C, Schmitz A, Fuhler GM, et al. Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138− and CD138+ plasma cells. Haematologica. 2010;95:1016–20.

    Article  PubMed  Google Scholar 

  28. Qian Y, Wei C, Eun-Hyung LF, Campbell J, Halliley J, Lee JA, et al. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin Cytom. 2010;78 Suppl 1:S69–82.

    PubMed  Google Scholar 

  29. Corso A, Castelli G, Pagnucco G, Lazzarino M, Bellio L, Klersy C, et al. Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status. Haematologica. 1997;82:43–6.

    PubMed  CAS  Google Scholar 

  30. Janols H, Bredberg A, Thuvesson I, Janciauskiene S, Grip O, Wullt M. Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders. BMC Infect Dis. 2010;10:205.

    Article  PubMed  Google Scholar 

  31. Roden AC, Morice WG, Hanson CA. Immunophenotypic attributes of benign peripheral blood gammadelta T cells and conditions associated with their increase. Arch Pathol Lab Med. 2008;132:1774–80.

    PubMed  Google Scholar 

  32. Lima M, Almeida J, Santos AH, dos Anjos TM, Alguero MC, Queiros ML, et al. Immunophenotypic analysis of the TCR-vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol. 2001;159:1861–8.

    Article  PubMed  CAS  Google Scholar 

  33. Weisberger J, Cornfield D, Gorczyca W, Liu Z. Down-regulation of pan-T-cell antigens, particularly CD7, in acute infectious mononucleosis. Am J Clin Pathol. 2003;1:49–55.

    Article  Google Scholar 

  34. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.

    Article  PubMed  CAS  Google Scholar 

  35. De Rosa SC, Brenchley JM, Roederer M. Beyond six colors: a new era in flow cytometry. Nat Med. 2003;9:112–7.

    Article  PubMed  Google Scholar 

  36. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev. 2006;20:123–37.

    Article  PubMed  CAS  Google Scholar 

  37. Deneys V, Mazzon AM, Marques JL, Benoit H, De BM. Reference values for peripheral blood B-lymphocyte subpopulations: a basis for multiparametric immunophenotyping of abnormal lymphocytes. J Immunol Methods. 2001;253:23–36.

    Article  PubMed  CAS  Google Scholar 

  38. Matutes E, Attygalle A, Wotherspoon A, Catovsky D. Diagnostic issues in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol. 2010;23:3–20.

    Article  PubMed  CAS  Google Scholar 

  39. Cro L, Ferrario A, Lionetti M, Bertoni F, Zucal NN, Nobili L, et al. The clinical and biological features of a series of immunophenotypic variant of B-CLL. Eur J Haematol. 2010;85:120–9.

    PubMed  CAS  Google Scholar 

  40. Sanchez ML, Almeida J, Gonzalez D, Gonzalez M, Garcia-Marcos MA, Balanzategui A, et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood. 2003;102:2994–3002.

    Article  PubMed  CAS  Google Scholar 

  41. Porwit A, Borgonovo L, Osby E, Lenkei R, Smith CI, Hammarstrom L. B-cell chronic lymphocytic leukaemia with aberrant expression of CD8 antigen. Eur J Haematol. 1987;39:311–7.

    Article  PubMed  CAS  Google Scholar 

  42. Carulli G, Stacchini A, Marini A, Ciriello MM, Zucca A, Cannizzo E, et al. Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltration. Am J Clin Pathol. 2009;132:186–90.

    Article  PubMed  CAS  Google Scholar 

  43. Rassenti LZ, Kipps TJ. Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2006;70:209–13.

    PubMed  Google Scholar 

  44. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005;130:325–32.

    Article  PubMed  Google Scholar 

  45. Shim YK, Middleton DC, Caporaso NE, Rachel JM, Landgren O, Abbasi F, et al. Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry B Clin Cytom. 2010;78 Suppl 1:S10–8.

    PubMed  Google Scholar 

  46. Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635–9.

    Article  PubMed  CAS  Google Scholar 

  47. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, et al. Monoclonal CD5+ and CD5− B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood. 2004;103:2337–42.

    Article  PubMed  CAS  Google Scholar 

  48. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF, et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood. 2009;114:33–7.

    Article  PubMed  CAS  Google Scholar 

  49. Rossi D, Sozzi E, Puma A, De Paoli L, Rasi S, Spina V, et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009;146:64–75.

    Article  PubMed  Google Scholar 

  50. Rawstron AC, Hillmen P. Clinical and diagnostic implications of monoclonal B-cell lymphocytosis. Best Pract Res Clin Haematol. 2010;23:61–9.

    Article  PubMed  CAS  Google Scholar 

  51. Tierens AM, Holte H, Warsame A, Ikonomou IM, Wang J, Chan WC, et al. Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type. Haematologica. 2010;95:1334–41.

    Article  PubMed  Google Scholar 

  52. Gao J, Peterson L, Nelson B, Goolsby C, Chen YH. Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol. 2009;132:699–706.

    Article  PubMed  Google Scholar 

  53. Golardi N, Velasco MR, Elghetany MT. Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma. Pathol Int. 2009;59:317–21.

    Article  PubMed  Google Scholar 

  54. Ho AK, Hill S, Preobrazhensky SN, Miller ME, Chen Z, Bahler DW. Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias. Am J Clin Pathol. 2009;131:27–32.

    Article  PubMed  Google Scholar 

  55. Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res. 2009;33:1212–6.

    Article  PubMed  CAS  Google Scholar 

  56. Kraus TS, Sillings CN, Saxe DF, Li S, Jaye DL. The role of CD11c expression in the diagnosis of mantle cell lymphoma. Am J Clin Pathol. 2010;134:271–7.

    Article  PubMed  Google Scholar 

  57. Swerdlow SH, Campo E, Seto M, Müller-Hermelink HK. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW editors WHO classification of tumours of haematopoietic and lymphatic tissues. 4th ed. Lyon: IARC; 2008 p229.

    Google Scholar 

  58. Jain P, Giustolisi GM, Atkinson S, Elnenaei MO, Morilla R, Owusu-Ankomah K, et al. Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry. J Clin Pathol. 2002;55:940–5.

    Article  PubMed  CAS  Google Scholar 

  59. Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, et al. Clinicopathologic features of Waldenstrom’s macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma. 2005;5:220–4.

    Article  PubMed  Google Scholar 

  60. Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, et al. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases. Haematologica. 2010;95:604–12.

    Article  PubMed  CAS  Google Scholar 

  61. Morice WG, Chen D, Kurtin PJ, Hanson CA, McPhail ED. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom’s macroglobulinemia. Mod Pathol. 2009;22:807–16.

    PubMed  CAS  Google Scholar 

  62. Kanellis G, Mollejo M, Montes-Moreno S, Rodriguez-Pinilla SM, Cigudosa JC, Algara P, et al. Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica. 2010;95:1122–9.

    Article  PubMed  Google Scholar 

  63. Dong HY, Weisberger J, Liu Z, Tugulea S. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. Am J Clin Pathol. 2009;131:586–95.

    Article  PubMed  CAS  Google Scholar 

  64. Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F, et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica. 2004;89:303–8.

    Google Scholar 

  65. Yang W, Agrawal N, Patel J, Edinger A, Osei E, Thut D, et al. Diminished expression of CD19 in B-cell lymphomas. Cytometry B Clin Cytom. 2005;63:28–35.

    PubMed  Google Scholar 

  66. Detry G, Drenou B, Ferrant A, Theate I, Michaux L, Scheiff JM, et al. Tracking the follicular lymphoma cells in flow cytometry: characterisation of a new useful antibody combination. Eur J Haematol. 2004;73(5):325–31.

    Article  PubMed  CAS  Google Scholar 

  67. Maleki A, Seegmiller AC, Uddin N, Karandikar NJ, Chen W. Bright CD38 expression is an indicator of MYC rearrangement. Leuk Lymphoma. 2009;50:1054–7.

    Article  PubMed  CAS  Google Scholar 

  68. Attarbaschi A, Mann G, Schumich A, Konig M, Pickl WF, Haas OA, et al. CD44 deficiency is a consistent finding in childhood Burkitt’s lymphoma and leukemia. Leukemia. 2007;21:1110–3.

    PubMed  CAS  Google Scholar 

  69. Schniederjan SD, Li S, Saxe DF, Lechowicz MJ, Lee KL, Terry PD, et al. A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma. Am J Clin Pathol. 2010;133:718–26.

    Article  PubMed  Google Scholar 

  70. Wu D, Wood BL, Dorer R, Fromm JR. “Double-Hit” mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression. Am J Clin Pathol. 2010;134:258–65.

    Article  PubMed  Google Scholar 

  71. Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5− with CD10+ groups may constitute clinically relevant subtypes. Leukemia. 1999;13:1441–7.

    Article  PubMed  CAS  Google Scholar 

  72. Palacio C, Acebedo G, Navarrete M, Ruiz-Marcellan C, Sanchez C, Blanco A, et al. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Haematologica. 2001;86:934–40.

    PubMed  CAS  Google Scholar 

  73. Talaulikar D, Shadbolt B, Bell J, Khan K, Dahlstrom JE, McDonald A, et al. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) – a new perspective. Histopathology. 2008;52:340–7.

    Article  PubMed  CAS  Google Scholar 

  74. Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, et al. Report of the European myeloma network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93:431–8.

    Article  PubMed  Google Scholar 

  75. Paiva B, Almeida J, Perez-Andres M, Mateo G, Lopez A, Rasillo A, et al. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders. Cytometry B Clin Cytom. 2010;78:239–52.

    PubMed  Google Scholar 

  76. Ocqueteau M, San Miguel JF, Gonzalez M, Almeida J, Orfao A. Do myelomatous plasma cells really express surface immunoglobulins? Haematologica. 1996;81:460–3.

    PubMed  CAS  Google Scholar 

  77. Paiva B, Vidriales MB, Perez JJ, Mateo G, Montalban MA, Mateos MV, et al. Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients. Haematologica. 2009;94:1599–602.

    Article  PubMed  Google Scholar 

  78. Paiva B, Vidriales MB, Mateo G, Perez JJ, Montalban MA, Sureda A, et al. The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients. Blood. 2009;114:4369–72.

    Article  PubMed  CAS  Google Scholar 

  79. Mateo G, Castellanos M, Rasillo A, Gutierrez NC, Montalban MA, Martin ML, et al. Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res. 2005;11:3661–7.

    Article  PubMed  CAS  Google Scholar 

  80. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104:328–35.

    Article  PubMed  CAS  Google Scholar 

  81. Cady FM, Morice WG. Flow cytometric assessment of T-cell chronic lymphoproliferative disorders. Clin Lab Med. 2007;27:513–32.

    Article  PubMed  Google Scholar 

  82. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington Jr W, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27:453–9.

    Article  PubMed  Google Scholar 

  83. Fierro MT, Novelli M, Quaglino P, Comessatti A, Fava P, Ortoncelli M, et al. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma. Dermatology. 2008;216:213–21.

    Article  PubMed  CAS  Google Scholar 

  84. Khokhar FA, Payne WD, Talwalkar SS, Jorgensen JL, Bueso-Ramos CE, Medeiros LJ, et al. Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study. Hum Pathol. 2010;41:79–87.

    Article  PubMed  CAS  Google Scholar 

  85. Damm-Welk C, Schieferstein J, Schwalm S, Reiter A, Woessmann W. Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction. Br J Haematol. 2007;138:459–66.

    Article  PubMed  CAS  Google Scholar 

  86. Muzzafar T, Wei EX, Lin P, Medeiros LJ, Jorgensen JL. Flow cytometric immunophenotyping of anaplastic large cell lymphoma. Arch Pathol Lab Med. 2009;133:49–56.

    PubMed  Google Scholar 

  87. Juco J, Holden JT, Mann KP, Kelley LG, Li S. Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. Am J Clin Pathol. 2003;119:205–12.

    Article  PubMed  Google Scholar 

  88. Shah MV, Zhang R, Loughran Jr TP. Never say die: survival signaling in large granular lymphocyte leukemia. Clin Lymphoma Myeloma. 2009;9 Suppl 3:S244–53.

    Article  PubMed  CAS  Google Scholar 

  89. Purdy AK, Campbell KS. Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). Cancer Biol Ther. 2009;8:2211–20.

    Article  PubMed  Google Scholar 

  90. Morice WG. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. Am J Clin Pathol. 2007;127:881–6.

    Article  PubMed  CAS  Google Scholar 

  91. Liang X, Graham DK. Natural killer cell neoplasms. Cancer. 2008;112:1425–36.

    Article  PubMed  Google Scholar 

  92. Yoo EH, Kim HJ, Lee ST, Kim WS, Kim SH. Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker. Korean J Lab Med. 2009;29:491–6.

    Article  PubMed  CAS  Google Scholar 

  93. Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261–9.

    Article  PubMed  CAS  Google Scholar 

  94. Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol. 2007;127:869–80.

    Article  PubMed  CAS  Google Scholar 

  95. Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, et al. Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol. 2009;6:707–17.

    Article  PubMed  Google Scholar 

  96. Bottcher S, Ritgen M, Buske S, Gesk S, Klapper W, Hoster E, et al. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. Haematologica. 2008;93:551–9.

    Article  PubMed  Google Scholar 

  97. Merli M, Arcaini L, Boveri E, Rattotti S, Picone C, Passamonti F, et al. Assessment of bone marrow involvement in non-Hodgkin’s lymphomas: comparison between histology and flow cytometry. Eur J Haematol. 2010;85:405–15.

    Article  PubMed  Google Scholar 

  98. Querfeld C, Mehta N, Rosen ST, Guitart J, Rademaker A, Gerami P, et al. Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H Lurie Comprehensive Cancer Center. Leuk Lymphoma. 2009;50:1969–76.

    Article  PubMed  CAS  Google Scholar 

  99. Dogan A, Morice WG. Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematol. 2004;127:140–54.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathobiology and Laboratory Medicine, University Health Network, Toronto General Hospital, Toronto, ON, Canada

    Anna Porwit M.D., Ph.D.

  2. Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden

    Anna Porwit M.D., Ph.D.

Authors
  1. Anna Porwit M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Porwit M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. , Department of Hematopathology, Evangelismos Hospital, Ersis Street 9, Athens, 15452, Greece

    Dimitra Anagnostou

  2. Royal Marsden Hospital, Inst. Cancer Research, NHS Foundation Trust, Fulham Road, London, SW3 6JJ, United Kingdom

    Estella Matutes

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Porwit, A. (2012). The Expanding Diagnostic Role of Flow Cytometry in Bone Marrow Studies of Patients with Lymphomas and Plasma Cell Disorders. In: Anagnostou, D., Matutes, E. (eds) Bone Marrow Lymphoid Infiltrates. Springer, London. https://doi.org/10.1007/978-1-4471-4174-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4174-7_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4173-0

  • Online ISBN: 978-1-4471-4174-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation